trending Market Intelligence /marketintelligence/en/news-insights/trending/kJe7-lOTXbPJOpl4Q4Yvuw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Perrigo Q1 adjusted net income drops YOY

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Perrigo Q1 adjusted net income drops YOY

Perrigo Co. PLC reported first-quarter adjusted net income of $150.1 million, or $1.05 per share, down from $188.9 million, or $1.32 per share, in the first quarter of 2016.

The S&P Capital IQ consensus normalized EPS estimate for the quarter was 99 cents.

Perrigo reported a GAAP net income of $71.6 million, or 50 cents per share, compared with a loss of $529.2 million, or $3.70 per share, in the year-ago period.

Net sales for the quarter were $1.19 billion, down 11% from $1.35 billion in the comparable year-ago quarter.

The decrease in net sales was mainly due to lower year-over-year contributions from net sales of existing products and the U.S. vitamin, mineral and supplement business which was sold in the third quarter of 2016. It was also due to the exit of the company's European distribution businesses, lower sales of Entocort, unfavorable foreign currency movements and discontinued products.

Perrigo expects its 2017 net sales to be in the range of $4.6 billion to $4.8 billion. The company expects its 2017 GAAP EPS in the range of $1.82 to $2.17 and adjusted EPS to be in the range of $4.15 to $4.50.

The S&P Capital IQ consensus normalized EPS estimate for 2017 is $4.30.